Neutral
●
PRNewsWire
●
vor 6 Monaten
MILWAUKEE, May 5, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against GeneDx (Nasdaq: WGS). The investigation results from inaccurate statements GeneDx may have made regarding its financial statements, business operations and prospects.